(Q53359495)

13 May 2018

title

The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma. (English)

1 reference

13 May 2018

cervical intraepithelial neoplasia

main subject

1 reference

Yinmei Dai

1

1 reference

13 May 2018

Xiangdong Zhang

series ordinal

2

1 reference

13 May 2018

Yunhua Peng

series ordinal

3

1 reference

13 May 2018

Ziren Wang

series ordinal

4

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 April 2005

1 reference

13 May 2018

published in

Gynecologic Oncology

1 reference

13 May 2018

volume

97

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

96-103

1 reference

13 May 2018

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Controversies in the management of low-grade cervical intraepithelial neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Positive and negative regulation of prostaglandin E2 biosynthesis in human colorectal carcinoma cells by cancer chemopreventive agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Inhibition of cyclooxygenase: a novel approach to cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

The effect of cyclooxygenase‐2 expression on tumor vascularity in advanced stage ovarian serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Role of cyclooxygenases in angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.020

10.1016/J.YGYNO.2004.12.020

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018